Interpreting Test Results

We know that >80% of women with threatened preterm labor are discharged and delivered at term.1 Fetal fibronectin (fFN) testing gives you an objective way to decide which patients face the highest risk for preterm delivery.


  1. Hedriana H, Byrne J, Campbell Bliss M, et al. March of Dimes Preterm Labor Assessment Toolkit. White Plains, NY: March of Dimes; 2013.

Preterm Birth Webinars

Leading clinicians discuss timely topics on the management of preterm birth.

View on


This link will take you to the information intended for healthcare professionals outside of the United States. Because these pages concern the international distribution activities of the QuikCheckTM fFN Test, which are not necessarily governed by US law, contents of the international pages may contain information that does not pertain to US users, including certain products that may not be cleared or approved by US Food & Drug Administration for promotion or sale in the United States. Click “Continue” to proceed, or click “Cancel” to remain in the US site.

Caution: The QuikCheck fFNTest is not sold or offered for sale in the United States or Canada.



You Are Leaving a Hologic Website

Hologic, Inc. does not review nor control the content on non-Hologic websites. This link does not constitute an endorsement by Hologic of the content of the site you are about to visit. Hologic privacy procedures do not apply to the owners of a non-Hologic website.